Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.640
-0.070 (-4.09%)
At close: Apr 1, 2025, 4:00 PM
1.600
-0.040 (-2.44%)
After-hours: Apr 1, 2025, 7:57 PM EDT
Lexaria Bioscience Balance Sheet
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 30, 2024 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 8.08 | 6.5 | 1.35 | 5.81 | 10.92 | 1.29 | Upgrade
|
| Short-Term Investments | 0.04 | 0.06 | 0.13 | 0.35 | 0.83 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 8.12 | 6.56 | 1.48 | 6.16 | 11.75 | 1.31 | Upgrade
|
| Cash Growth | 300.58% | 343.63% | -76.01% | -47.58% | 794.97% | -2.69% | Upgrade
|
| Accounts Receivable | 0.17 | 0.08 | 0.02 | 0.12 | 0.02 | 0.23 | Upgrade
|
| Other Receivables | 0.09 | 0.07 | 0.1 | 0.08 | 0.33 | 0.09 | Upgrade
|
| Receivables | 0.26 | 0.15 | 0.13 | 0.2 | 0.34 | 0.31 | Upgrade
|
| Inventory | - | - | - | 0.04 | 0.03 | 0.12 | Upgrade
|
| Prepaid Expenses | 0.44 | 1.19 | 0.55 | 0.58 | 0.32 | 0.18 | Upgrade
|
| Total Current Assets | 8.83 | 7.9 | 2.15 | 6.98 | 12.44 | 1.93 | Upgrade
|
| Property, Plant & Equipment | 0.4 | 0.39 | 0.42 | 0.37 | 0.46 | 0.61 | Upgrade
|
| Other Intangible Assets | 0.51 | 0.52 | 0.46 | 0.49 | 0.36 | 0.29 | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.06 | 0.05 | - | - | - | Upgrade
|
| Total Assets | 9.79 | 8.87 | 3.08 | 7.83 | 13.27 | 2.83 | Upgrade
|
| Accounts Payable | 0.26 | 0.38 | 0.23 | 0.12 | 0.06 | 0.05 | Upgrade
|
| Accrued Expenses | 0.01 | 0.69 | 0.01 | 0.03 | 0.05 | 0.1 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.01 | - | Upgrade
|
| Current Portion of Leases | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0 | 0 | Upgrade
|
| Current Unearned Revenue | - | 0 | - | - | - | 0.04 | Upgrade
|
| Total Current Liabilities | 0.3 | 1.1 | 0.27 | 0.19 | 0.15 | 0.23 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.03 | Upgrade
|
| Long-Term Leases | 0.1 | 0.11 | 0.14 | 0.01 | 0.05 | 0.09 | Upgrade
|
| Total Liabilities | 0.4 | 1.21 | 0.4 | 0.2 | 0.2 | 0.35 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 64.04 | 59.6 | 48.8 | 47.04 | 45.09 | 30.32 | Upgrade
|
| Retained Earnings | -54.26 | -51.56 | -45.76 | -39.1 | -31.83 | -27.8 | Upgrade
|
| Comprehensive Income & Other | -0.02 | -0.02 | - | - | - | - | Upgrade
|
| Total Common Equity | 9.77 | 8.04 | 3.04 | 7.95 | 13.27 | 2.53 | Upgrade
|
| Minority Interest | -0.38 | -0.38 | -0.36 | -0.32 | -0.2 | -0.04 | Upgrade
|
| Shareholders' Equity | 9.39 | 7.66 | 2.68 | 7.63 | 13.06 | 2.48 | Upgrade
|
| Total Liabilities & Equity | 9.79 | 8.87 | 3.08 | 7.83 | 13.27 | 2.83 | Upgrade
|
| Total Debt | 0.13 | 0.14 | 0.16 | 0.05 | 0.1 | 0.16 | Upgrade
|
| Net Cash (Debt) | 7.99 | 6.42 | 1.31 | 6.11 | 11.65 | 1.16 | Upgrade
|
| Net Cash Growth | 326.79% | 388.54% | -78.50% | -47.57% | 907.32% | -14.26% | Upgrade
|
| Net Cash Per Share | 0.56 | 0.52 | 0.20 | 1.04 | 2.65 | 0.42 | Upgrade
|
| Filing Date Shares Outstanding | 17.55 | 17.45 | 10.28 | 5.95 | 5.73 | 3 | Upgrade
|
| Total Common Shares Outstanding | 17.45 | 15.81 | 8.09 | 5.95 | 5.73 | 3 | Upgrade
|
| Working Capital | 8.53 | 6.8 | 1.88 | 6.78 | 12.29 | 1.7 | Upgrade
|
| Book Value Per Share | 0.56 | 0.51 | 0.38 | 1.34 | 2.32 | 0.84 | Upgrade
|
| Tangible Book Value | 9.27 | 7.52 | 2.58 | 7.46 | 12.9 | 2.23 | Upgrade
|
| Tangible Book Value Per Share | 0.53 | 0.48 | 0.32 | 1.25 | 2.25 | 0.74 | Upgrade
|
| Machinery | 0.51 | 0.51 | 0.47 | 0.44 | 0.39 | 0.39 | Upgrade
|
| Leasehold Improvements | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | Upgrade
|
Updated Jan 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.